|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.280 USD | -1.72% |
|
-10.29% | -28.80% |
| May. 07 | Vanda Pharmaceuticals Inc., Q1 2026 Earnings Call, May 06, 2026 | |
| May. 06 | Vanda Pharmaceuticals Inc. Raises Revenue Guidance for the Full-Year 2026 | CI |
| Capitalization | 378M 321M 294M 277M 517M 35.67B 522M 3.48B 1.36B 17.13B 1.42B 1.39B 59.15B | P/E ratio 2026 * |
-2.5x | P/E ratio 2027 * | -7.66x |
|---|---|---|---|---|---|
| Enterprise value | 243M 207M 189M 178M 333M 22.96B 336M 2.24B 874M 11.03B 912M 893M 38.08B | EV / Sales 2026 * |
0.93x | EV / Sales 2027 * | 0.76x |
| Free-Float |
90.51% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Vanda Pharmaceuticals Inc.
| 1 day | -1.72% | ||
| 1 week | -10.29% | ||
| Current month | -11.55% | ||
| 1 month | -13.85% | ||
| 3 months | -17.04% | ||
| 6 months | +42.73% | ||
| Current year | -28.80% |
| 1 week | 6.2 |  | 7.74 |
| 1 month | 6.2 | | 7.74 |
| Current year | 5.73 | | 9.94 |
| 1 year | 3.81 | | 9.94 |
| 3 years | 3.3 | | 9.94 |
| 5 years | 3.3 | | 21.86 |
| 10 years | 3.3 | | 33.44 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 66 | 2003-04-30 | |
Kevin Moran
DFI | Director of Finance/CFO | 42 | 2020-03-14 |
Scott Howell
HRO | Human Resources Officer | - | 2019-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 66 | 2021-05-31 | |
Richard Dugan
BRD | Director/Board Member | 84 | 2005-11-30 |
Phaedra Chrousos
BRD | Director/Board Member | 46 | 2019-04-23 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.72% | -10.29% | +48.82% | -9.38% | 378M | |
| -4.03% | -2.51% | +81.08% | +57.71% | 47.65B | |
| -0.06% | +0.42% | +37.94% | +83.93% | 49.1B | |
| +1.19% | -3.50% | -0.69% | -12.89% | 23.8B | |
| -3.48% | -23.95% | +54.43% | +436.24% | 21.97B | |
| -1.86% | -1.15% | +44.83% | -31.10% | 17.26B | |
| -6.65% | -3.10% | +27.25% | -40.24% | 15.88B | |
| -2.83% | -1.33% | +59.05% | +199.44% | 15.77B | |
| -1.71% | -4.73% | +36.01% | - | 13.32B | |
| +5.42% | +12.19% | -26.65% | +831.96% | 14.03B | |
| Average | -1.57% | -3.94% | +36.21% | +168.41% | 21.92B | |
| Weighted average by Cap. | -1.70% | -3.48% | +41.83% | +144.71% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 262M 223M 204M 193M 359M 24.78B 362M 2.42B 943M 11.9B 984M 964M 41.09B | 354M 301M 275M 260M 484M 33.42B 489M 3.26B 1.27B 16.06B 1.33B 1.3B 55.43B |
| Net income | -153M -130M -119M -112M -209M -14.43B -211M -1.41B -549M -6.93B -573M -561M -23.93B | -66.29M -56.32M -51.54M -48.65M -90.75M -6.26B -91.55M -611M -238M -3.01B -249M -243M -10.38B |
| Net Debt | -135M -114M -105M -98.74M -184M -12.71B -186M -1.24B -484M -6.1B -505M -494M -21.07B | -110M -93.8M -85.84M -81.02M -151M -10.43B -152M -1.02B -397M -5.01B -414M -405M -17.29B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-05-08 | 6.280 $ | -1.72% | 1,309,361 |
| 26-05-07 | 6.390 $ | -14.11% | 2,250,814 |
| 26-05-06 | 7.440 $ | +0.68% | 1,691,049 |
| 26-05-05 | 7.390 $ | -2.25% | 895,624 |
| 26-05-04 | 7.560 $ | +8.00% | 1,807,489 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- VNDA Stock
Select your edition
All financial news and data tailored to specific country editions
